| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Sep 1 | M | 2,694 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Sep 1 | M | 1,750 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Sep 1 | M | 1,591 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Sep 1 | M | 3,069 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Sep 1 | A | 31,150 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Sep 1 | A | 7,800 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Sep 1 | F | 4,404 | $79.28 | $349K |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Sep 1 | M | 3,069 | — | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Sep 1 | M | 1,591 | — | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Sep 1 | M | 1,750 | — | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Sep 1 | M | 2,694 | — | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Apr 7 | M | 2,694 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Apr 7 | F | 1,303 | $48.94 | $64K |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Apr 7 | M | 2,694 | — | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Apr 1 | M | 1,846 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Apr 1 | M | 1,591 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Apr 1 | M | 1,750 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Apr 1 | A | 15,600 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Apr 1 | A | 7,800 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Apr 1 | A | 31,150 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Apr 1 | F | 2,510 | $48.13 | $121K |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Apr 1 | M | 5,187 | — | — |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Mar 9 | MPLAN | 10,360 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Mar 9 | MPLAN | 13,813 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Mar 9 | MPLAN | 10,513 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Mar 9 | MPLAN | 2,036 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Mar 9 | SPLAN | 18,741 | $46.24 | $867K |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Mar 9 | SPLAN | 17,981 | $45.58 | $820K |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Mar 9 | MPLAN | 10,360 | $26.74 | $277K |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Mar 9 | MPLAN | 13,813 | $18.06 | $249K |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Mar 9 | MPLAN | 10,513 | $17.76 | $187K |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Mar 9 | MPLAN | 2,036 | $22.89 | $47K |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Feb 9 | MPLAN | 2,471 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFODERIV | Feb 9 | MPLAN | 8,374 | $0.00 | —? |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Feb 9 | SPLAN | 8,731 | $43.72 | $382K |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Feb 9 | SPLAN | 9,114 | $42.85 | $391K |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Feb 9 | MPLAN | 2,471 | $16.90 | $42K |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Feb 9 | MPLAN | 8,374 | $12.97 | $109K |
| Kiniksa Pharmaceuticals International, plc | KNSA | Mark RagosaCFO | Jan 8 | SPLAN | 12,000 | $41.89 | $503K |